These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 12552451

  • 1. Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
    Wallis RS, Vinhas SA, Johnson JL, Ribeiro FC, Palaci M, Peres RL, Sá RT, Dietze R, Chiunda A, Eisenach K, Ellner JJ.
    J Infect Dis; 2003 Jan 15; 187(2):270-8. PubMed ID: 12552451
    [Abstract] [Full Text] [Related]

  • 2. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH, Patientia RF, Venter A, van Helden PD, Smith PJ, McIlleron H, Maritz JS, Donald PR.
    Antimicrob Agents Chemother; 2007 Aug 15; 51(8):2994-6. PubMed ID: 17517849
    [Abstract] [Full Text] [Related]

  • 3. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR, Diacon AH.
    Tuberculosis (Edinb); 2008 Aug 15; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL, Yew WW, Ma WK, Girling DJ, Aber VR, Felmingham D, Allen BW, Mitchison DA.
    Tuber Lung Dis; 1992 Feb 15; 73(1):33-8. PubMed ID: 1326348
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa, Zhangireev AA, Sidorenko OA.
    Probl Tuberk Bolezn Legk; 2008 Feb 15; (5):20-2. PubMed ID: 18711814
    [Abstract] [Full Text] [Related]

  • 11. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB, Reddy VC, Gokhale S, Moorthy KV.
    Trans R Soc Trop Med Hyg; 2009 Jun 15; 103(6):564-70. PubMed ID: 19243801
    [Abstract] [Full Text] [Related]

  • 12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 15; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis.
    Wallis RS, Dawson R, Friedrich SO, Venter A, Paige D, Zhu T, Silvia A, Gobey J, Ellery C, Zhang Y, Eisenach K, Miller P, Diacon AH.
    PLoS One; 2014 Oct 15; 9(4):e94462. PubMed ID: 24732289
    [Abstract] [Full Text] [Related]

  • 15. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG, Gao Z, Fan BD.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb 15; 26(2):74-6. PubMed ID: 12783655
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model.
    Naftalin CM, Verma R, Gurumurthy M, Hee KH, Lu Q, Yeo BCM, Tan KH, Lin W, Yu B, Seng KY, Lee LS, Paton NI.
    Sci Rep; 2018 Sep 10; 8(1):13491. PubMed ID: 30202030
    [Abstract] [Full Text] [Related]

  • 19. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
    Fortún J, Martín-Dávila P, Molina A, Navas E, Hermida JM, Cobo J, Gómez-Mampaso E, Moreno S.
    J Antimicrob Chemother; 2007 Apr 10; 59(4):794-8. PubMed ID: 17392354
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS.
    J Antimicrob Chemother; 2006 Sep 10; 58(3):701-4. PubMed ID: 16857689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.